Medicamen Biotech Share Price

Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industry. The Company’s focus areas include antibiotics, hypertension, general pain management, cardiovascular, diabetics and oncology formulations. In cardiology, the Company is delivering effective treatments for heart-related conditions. Its CNS products address neurological disorders, while its diabetology solutions focus on advanced diabetes management. It also contributes to the global fight against malaria with its anti-malarial medications. Additionally, the Company offers essential vitamins, antibiotics for bacterial infections, and comprehensive pain management solutions. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, and others.As of 27 May 2026, Medicamen Biotech share price is ₹275.40. The stock opened at ₹270.50, compared to its previous close of ₹272.30. During today's trading session, Medicamen Biotech share price moved in the range of ₹270.50 to ₹279.90, with an average price of ₹275.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹270.50 and a high of ₹279.90. On the performance front, Medicamen Biotech share price has declined by 33.98% over the last six months and is down 36.84% on a year-on-year basis.

The market capitalization of Medicamen Biotech is ₹368 Crs, with a P/E ratio of 50.4 and a dividend yield of 0.35%.